Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Novanta stock | 115.33

Own Novanta stock in just a few minutes.

Posted

Fact checked

Novanta Inc is a scientific & technical instruments business based in the US. Novanta shares (NOVT) are listed on the NASDAQ and all prices are listed in US Dollars. Novanta employs 2,290 staff and has a trailing 12-month revenue of around USD$602.8 million.

How to buy shares in Novanta

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Novanta. Find the stock by name or ticker symbol: NOVT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Novanta reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$115.33, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Novanta, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Novanta. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Novanta's share price?

Since the stock market crash in March caused by coronavirus, Novanta's share price has had significant positive movement.

Its last market close was USD$115.33, which is 18.49% up on its pre-crash value of USD$94.01 and 73.59% up on the lowest point reached during the March crash when the shares fell as low as USD$66.44.

If you had bought USD$1,000 worth of Novanta shares at the start of February 2020, those shares would have been worth USD$794.27 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,224.80.

Novanta share price

Use our graph to track the performance of NOVT stocks over time.

Novanta shares at a glance

Information last updated 2020-11-25.
Latest market close USD$115.33
52-week range USD$66.44 - USD$127.91
50-day moving average USD$114.4761
200-day moving average USD$107.1361
Wall St. target price USD$118
PE ratio 99.6087
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.15

Buy Novanta shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Novanta stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Novanta price performance over time

Historical closes compared with the close of $115.33 from 2020-11-16

1 week (2020-11-20) N/A
1 month (2020-10-30) 6.08%
3 months (2020-08-28) N/A
6 months (2020-05-28) N/A
1 year (2019-11-27) N/A
2 years (2018-11-27) N/A
3 years (2017-11-27) N/A
5 years (2015-11-27) N/A

Is Novanta under- or over-valued?

Valuing Novanta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Novanta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Novanta's P/E ratio

Novanta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 100x. In other words, Novanta shares trade at around 100x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Novanta's PEG ratio

Novanta's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novanta's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Novanta's EBITDA

Novanta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$101.7 million.

The EBITDA is a measure of a Novanta's overall financial performance and is widely used to measure a its profitability.

Novanta financials

Revenue TTM USD$602.8 million
Operating margin TTM 10.46%
Gross profit TTM USD$263.4 million
Return on assets TTM 4.59%
Return on equity TTM 9.62%
Profit margin 6.82%
Book value $12.834
Market capitalisation USD$4.2 billion

TTM: trailing 12 months

Shorting Novanta shares

There are currently 427,199 Novanta shares held short by investors – that's known as Novanta's "short interest". This figure is 5.5% up from 404,784 last month.

There are a few different ways that this level of interest in shorting Novanta shares can be evaluated.

Novanta's "short interest ratio" (SIR)

Novanta's "short interest ratio" (SIR) is the quantity of Novanta shares currently shorted divided by the average quantity of Novanta shares traded daily (recently around 89372.175732218). Novanta's SIR currently stands at 4.78. In other words for every 100,000 Novanta shares traded daily on the market, roughly 4780 shares are currently held short.

However Novanta's short interest can also be evaluated against the total number of Novanta shares, or, against the total number of tradable Novanta shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Novanta's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Novanta shares in existence, roughly 10 shares are currently held short) or 0.0125% of the tradable shares (for every 100,000 tradable Novanta shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Novanta.

Find out more about how you can short Novanta stock.

Novanta share dividends

We're not expecting Novanta to pay a dividend over the next 12 months.

Have Novanta's shares ever split?

Novanta's shares were split on a 1:3 basis on 29 December 2010. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novanta shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Novanta shares which in turn could have impacted Novanta's share price.

Novanta share price volatility

Over the last 12 months, Novanta's shares have ranged in value from as little as $66.44 up to $127.91. A popular way to gauge a stock's volatility is its "beta".

NOVT.US volatility(beta: 1.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novanta's is 1.1623. This would suggest that Novanta's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Novanta overview

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site